Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Ann Surg Oncol. 2012 Oct 27;20(4):1216–1222. doi: 10.1245/s10434-012-2706-7

FIG. 3.

FIG. 3

Cumulative survival rates in relation to the presence of pre-S2 deletion in HBV in patients with HBeAg-negative HBV-associated HCC (n = 161). Patients with pre-S2 deletion tended to have lower survival rates than those without pre-S2 deletion (P = 0.129)